Integral Health Asset Management, LLC Forma Therapeutics Holdings, Inc. Transaction History

Integral Health Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $270,923 - $770,152	-38,051 Reduced 29.26%	92,000 $3.31 Million
Q2 2022 Aug 03, 2022	BUY	$5.1 - $10.0 $204,260 - $400,510	40,051 Added 44.5%	130,051 $896,000
Q1 2022 May 12, 2022	BUY	$8.34 - $14.69 $125,100 - $220,350	15,000 Added 20.0%	90,000 $837,000
Q4 2021 Feb 02, 2022	BUY	$13.6 - $24.89 $204,000 - $373,350	15,000 Added 25.0%	75,000 $1.07 Million
Q3 2021 Nov 12, 2021	BUY	$21.22 - $25.7 $318,300 - $385,500	15,000 Added 33.33%	60,000 $1.39 Million
Q2 2021 Aug 30, 2021	SELL	$22.86 - $30.95 $1.03 Million - $1.39 Million	-45,000 Reduced 50.0%	45,000 $1.12 Million
Q2 2021 Aug 13, 2021	BUY	$22.86 - $30.95 $2.06 Million - $2.79 Million	90,000 New	90,000 $2.24 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.